List of Contents

Patient Monitoring Devices Market Size, Share, and Trends 2024 to 2034

The global patient monitoring devices market size was USD 44.44 billion in 2023, calculated at USD 48.18 billion in 2024 and is projected to surpass around USD 107.93 billion by 2034, expanding at a CAGR of 8.4% from 2024 to 2034.

  • Last Updated : September 2024
  • Report Code : 1288
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Patient Monitoring Devices Market, By Product

7.1. Patient Monitoring Devices Market, by Product Type, 2024-2034

7.1.1. Cardiac Monitoring Devices

7.1.1.1. Market Revenue and Forecast (2021-2034)

7.1.2. Blood Glucose Monitoring Systems

7.1.2.1. Market Revenue and Forecast (2021-2034)

7.1.3. Multi-parameter Monitoring Devices

7.1.3.1. Market Revenue and Forecast (2021-2034)

7.1.4. Temperature Monitoring Devices

7.1.4.1. Market Revenue and Forecast (2021-2034)

7.1.5. Respiratory Monitoring Devices

7.1.5.1. Market Revenue and Forecast (2021-2034)

7.1.6. Hemodynamic/Pressure Monitoring Devices

7.1.6.1. Market Revenue and Forecast (2021-2034)

7.1.7. Fetal & Neonatal Monitoring Devices

7.1.7.1. Market Revenue and Forecast (2021-2034)

7.1.8. Neuromonitoring Devices

7.1.8.1. Market Revenue and Forecast (2021-2034)

7.1.9. Weight Monitoring Devices

7.1.9.1. Market Revenue and Forecast (2021-2034)

7.1.10. Others

7.1.10.1. Market Revenue and Forecast (2021-2034)

Chapter 8. Global Patient Monitoring Devices Market, By End-use

8.1. Patient Monitoring Devices Market, by End-use, 2024-2034

8.1.1. Hospitals

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Home Care Settings

8.1.2.1. Market Revenue and Forecast (2021-2034)

8.1.3. Ambulatory Surgery Centers

8.1.3.1. Market Revenue and Forecast (2021-2034)

8.1.4. Others

8.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Patient Monitoring Devices Market, Regional Estimates and Trend Forecast

9.1. North America

9.1.1. Market Revenue and Forecast, by Product (2021-2034)

9.1.2. Market Revenue and Forecast, by End-use (2021-2034)

9.1.3. U.S.

9.1.3.1. Market Revenue and Forecast, by Product (2021-2034)

9.1.3.2. Market Revenue and Forecast, by End-use (2021-2034)

9.1.4. Rest of North America

9.1.4.1. Market Revenue and Forecast, by Product (2021-2034)

9.1.4.2. Market Revenue and Forecast, by End-use (2021-2034)

9.2. Europe

9.2.1. Market Revenue and Forecast, by Product (2021-2034)

9.2.2. Market Revenue and Forecast, by End-use (2021-2034)

9.2.3. UK

9.2.3.1. Market Revenue and Forecast, by Product (2021-2034)

9.2.3.2. Market Revenue and Forecast, by End-use (2021-2034)

9.2.4. Germany

9.2.4.1. Market Revenue and Forecast, by Product (2021-2034)

9.2.4.2. Market Revenue and Forecast, by End-use (2021-2034)

9.2.5. France

9.2.5.1. Market Revenue and Forecast, by Product (2021-2034)

9.2.5.2. Market Revenue and Forecast, by End-use (2021-2034)

9.2.6. Rest of Europe

9.2.6.1. Market Revenue and Forecast, by Product (2021-2034)

9.2.6.2. Market Revenue and Forecast, by End-use (2021-2034)

9.3. APAC

9.3.1. Market Revenue and Forecast, by Product (2021-2034)

9.3.2. Market Revenue and Forecast, by End-use (2021-2034)

9.3.3. India

9.3.3.1. Market Revenue and Forecast, by Product (2021-2034)

9.3.3.2. Market Revenue and Forecast, by End-use (2021-2034)

9.3.4. China

9.3.4.1. Market Revenue and Forecast, by Product (2021-2034)

9.3.4.2. Market Revenue and Forecast, by End-use (2021-2034)

9.3.5. Japan

9.3.5.1. Market Revenue and Forecast, by Product (2021-2034)

9.3.5.2. Market Revenue and Forecast, by End-use (2021-2034)

9.3.6. Rest of APAC

9.3.6.1. Market Revenue and Forecast, by Product (2021-2034)

9.3.6.2. Market Revenue and Forecast, by End-use (2021-2034)

9.4. MEA

9.4.1. Market Revenue and Forecast, by Product (2021-2034)

9.4.2. Market Revenue and Forecast, by End-use (2021-2034)

9.4.3. GCC

9.4.3.1. Market Revenue and Forecast, by Product (2021-2034)

9.4.3.2. Market Revenue and Forecast, by End-use (2021-2034)

9.4.4. North Africa

9.4.4.1. Market Revenue and Forecast, by Product (2021-2034)

9.4.4.2. Market Revenue and Forecast, by End-use (2021-2034)

9.4.5. South Africa

9.4.5.1. Market Revenue and Forecast, by Product (2021-2034)

9.4.5.2. Market Revenue and Forecast, by End-use (2021-2034)

9.4.6. Rest of MEA

9.4.6.1. Market Revenue and Forecast, by Product (2021-2034)

9.4.6.2. Market Revenue and Forecast, by End-use (2021-2034)

9.5. Latin America

9.5.1. Market Revenue and Forecast, by Product (2021-2034)

9.5.2. Market Revenue and Forecast, by End-use (2021-2034)

9.5.3. Brazil

9.5.3.1. Market Revenue and Forecast, by Product (2021-2034)

9.5.3.2. Market Revenue and Forecast, by End-use (2021-2034)

9.5.4. Rest of LATAM

9.5.4.1. Market Revenue and Forecast, by Product (2021-2034)

9.5.4.2. Market Revenue and Forecast, by End-use (2021-2034)

Chapter 10. Company Profiles

10.1. Abbott Laboratories

10.1.1. Company Overview

10.1.2. Product Offerings

10.1.3. Financial Performance

10.1.4. Recent Initiatives

10.2. Hill-Rom Holdings, Inc.

10.2.1. Company Overview

10.2.2. Product Offerings

10.2.3. Financial Performance

10.2.4. Recent Initiatives

10.3. Drägerwerk AG & Co. KGaA

10.3.1. Company Overview

10.3.2. Product Offerings

10.3.3. Financial Performance

10.3.4. Recent Initiatives

10.4. Edwards Lifesciences Corporation

10.4.1. Company Overview

10.4.2. Product Offerings

10.4.3. Financial Performance

10.4.4. Recent Initiatives

10.5. OMRON Corporation

10.5.1. Company Overview

10.5.2. Product Offerings

10.5.3. Financial Performance

10.5.4. Recent Initiatives

10.6. Masimo Corporation

10.6.1. Company Overview

10.6.2. Product Offerings

10.6.3. Financial Performance

10.6.4. Recent Initiatives

10.7. Compumedics Limited

10.7.1. Company Overview

10.7.2. Product Offerings

10.7.3. Financial Performance

10.7.4. Recent Initiatives

10.8. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

10.8.1. Company Overview

10.8.2. Product Offerings

10.8.3. Financial Performance

10.8.4. Recent Initiatives

10.9. Nihon Kohden Corporation

10.9.1. Company Overview

10.9.2. Product Offerings

10.9.3. Financial Performance

10.9.4. Recent Initiatives

10.10. Natus Medical

10.10.1. Company Overview

10.10.2. Product Offerings

10.10.3. Financial Performance

10.10.4. Recent Initiatives

Chapter 11. Research Methodology

11.1. Primary Research

11.2. Secondary Research

11.3. Assumptions

Chapter 12. Appendix

12.1. About Us

12.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The patient monitoring devices market size was surpassed at USD 44.44 billion in 2023 and is projected to reach around USD 107.93 billion by 2034 with a CAGR of 8.4% from 2024 to 2034.

Rise in chronic diseases across the globe especially in the older generation people, increase in older population across the globe and the rapid technological advancement in the patient monitoring devices are the key driving factors for patient monitoring devices market growth.

The major market player includes in patient monitoring devices market are Abbott Laboratories, Hill-Rom Holdings, Inc., Drägerwerk AG & Co. KGaA, Edwards Lifesciences Corporation, OMRON Corporation, Masimo Corporation, Compumedics Limited, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Nihon Kohden Corporation, Natus Medical, Medtronic plc (Ireland), Koninklijke Philips N.V., GE Healthcare, Getinge AB, Boston Scientific Corporation, Dexcom, Inc., Nonin, BIOTRONIK, SCHILLER, and BioTelemetry, Inc..

The cardiac monitoring devices segment hold revenue share of 20.1% in 2023 due to increase in cardiovascular disease across the world leading to stroke and heart attack.

The North America region is expected to lead the market with market share of more than 43% in 2023 .

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Plan your call and get expert insights!

Schedule a Meeting Schedule a Meeting

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us